LAVAL, QC / ACCESS Newswire / September 5, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company,…
~Pivotal Launch-HTN trial of novel aldosterone synthase inhibitor lorundrostat enrolled a diverse range of participants with uncontrolled or resistant hypertension~…
First dual-acting anti-inflammatory and anti-fibrotic candidate in development for FSCD, a condition with no approved therapies Patient dosing expected to…
FLORHAM PARK, N.J., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused…
BOSTON, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company…
Free 3-day online event brings together 30+ global leaders to unite functional and longevity medicine with cutting-edge science and clinical…
As the Trump administration cracks down on foreign drug cartels, MMJ BioPharma Cultivation exposes a hypocritical domestic policy: rewarding illegal…
VANCOUVER, BC / ACCESS Newswire / September 5, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:4XT), is pleased…
My Compounding Pharmacy: Revolutionizing Thyroid Treatment Through Personalized Medication Solutions ROSELANDS, AU / ACCESS Newswire / September 4, 2025 /…
BOSTON, Sept. 4, 2025 /PRNewswire/ -- Holly Polglase, a seasoned litigator with extensive experience in the defense and trial of…